A carregar...
Organoid technology for personalized pancreatic cancer therapy
BACKGROUND: Pancreatic ductal adenocarcinoma has the lowest survival rate among all major cancers and is the third leading cause of cancer-related mortality. The stagnant survival statistics and dismal response rates to current therapeutics highlight the need for more efficient preclinical models. P...
Na minha lista:
| Publicado no: | Cell Oncol (Dordr) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Netherlands
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7985124/ https://ncbi.nlm.nih.gov/pubmed/33492660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13402-021-00585-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|